CVE:NU

NeutriSci International - NU Stock Forecast, Price & News

C$0.02

0.00 (0.00%)

(As of 03/16/2023 05:42 PM ET)

Add

Compare

Today's Range: C$0.02
▼
C$0.02
50-Day Range: C$0.01
▼
C$0.02
52-Week Range: C$0.01
▼
C$0.06

Volume: 33,000 shs
Average Volume: 73,956 shs
Market Capitalization: C$2.68 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

About NeutriSci International

NeutriSci International Inc. develops, markets, and distributes nutraceutical products in Canada, the United States, Europe, Asia, and South America. It offers neuenergy, an energy tablet designed to deliver enhanced focus and mental clarity. The company sells its products through a distribution network of retail and online channels. NeutriSci International Inc. has partnership with LaSanta Botanicals, Nutritional High, and Naturally Splendid. NeutriSci International Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.

Receive NU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NeutriSci International and its competitors with MarketBeat's FREE daily newsletter.

NU Stock News Headlines

January 29, 2021 | markets.businessinsider.com

NeutriSci Closes Financing

January 19, 2021 | finanznachrichten.de

NeutriSci International Inc: NeutriSci Receives Multi Million Dollar Order for Japanese Market

March 20, 2023 | Stansberry Research (Ad)

The gold catalyst we’ve waited for

If you thought the SVB meltdown was bad… watch out. Because even bigger red flag just appeared. This signal proves that a recession is likely right around the corner. It will take most by surprise. Stocks will crash. Millions will go jobless, and lose their homes. But there is ONE important step you should take today to make sure you come out the other side OK.

December 26, 2020 | markets.businessinsider.com

NeutriSci International Inc Stock , NRXCF

December 24, 2020 | markets.businessinsider.com

News for NeutriSci International Inc

December 14, 2020 | benzinga.com

NeutriSci's Contract Partner, Tabletz LLC, Provides Update on Product Launch in Japan

December 12, 2020 | finanznachrichten.de

NeutriSci International Inc: NeutriSci Provides Update on Washington State Approval and Expansion into Oklahoma

October 28, 2020 | finanznachrichten.de

NeutriSci International Inc: Neutrisci Provides Update on Product Launch in Japan

March 20, 2023 | Stansberry Research (Ad)

The gold catalyst we’ve waited for

July 16, 2020 | markets.businessinsider.com

IIROC Trading Resumption - NU

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive NU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NeutriSci International and its competitors with MarketBeat's FREE daily newsletter.

NU Company Calendar

Today: 3/20/2023
Next Earnings (Estimated): 3/21/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: CVE
Industry: Drug Manufacturers - Specialty & Generic
Sub-Industry: N/A
Sector: Medical
Current Symbol: CVE:NU
CUSIP: N/A
CIK: N/A
Web: www.neutrisci.com
Phone: 403-264-6320
Fax: N/A
Employees: 147,000
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: -211.94%
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: -91.44%

Debt

Debt-to-Equity Ratio: 20.93
Current Ratio: 0.16
Quick Ratio: 0.02

Sales & Book Value

Annual Sales: C$432,451.00
Price / Sales: 6.19
Cash Flow: C$0.00 per share
Price / Cash Flow: 25.00
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 178,420,000
Free Float: N/A
Market Cap: C$2.68 million
Optionable: Not Optionable
Beta: 1.05

Key Executives

Mr. Glen Rehman
CEO, Pres & Director

Mr. John Robert Chisholm (Age 61)
Chief Financial Officer

Ms. Jaycee Waters
Operations & Logistics Mang.

Mr. Thierry Sorhaitz
VP of Sales & Marketing

Key Competitors

View All Competitors

NU Stock - Frequently Asked Questions

How have NU shares performed in 2023?: NeutriSci International's stock was trading at C$0.02 at the start of the year. Since then, NU shares have increased by 0.0% and is now trading at C$0.02.
View the best growth stocks for 2023 here.
When is NeutriSci International's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, March 21st 2023.
View our NU earnings forecast.
What other stocks do shareholders of NeutriSci International own?: Based on aggregate information from My MarketBeat watchlists, some companies that other NeutriSci International investors own include Aurora Cannabis (ACB), EMCOR Group (EME), Incyte (INCY), Northwest Pipe (NWPX), UnitedHealth Group (UNH), Watsco (WSO), Zimmer Biomet (ZBH), 3i Infrastructure (3IN), Axos Financial (AX) and Actinium Pharmaceuticals (ATNM).
What is NeutriSci International's stock symbol?: NeutriSci International trades on the Canadian Venture Exchange (CVE) under the ticker symbol "NU."

How do I buy shares of NeutriSci International?: Shares of NU stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.
What is NeutriSci International's stock price today?: One share of NU stock can currently be purchased for approximately C$0.02.
How much money does NeutriSci International make?: NeutriSci International (CVE:NU) has a market capitalization of C$2.68 million and generates C$432,451.00 in revenue each year.
How many employees does NeutriSci International have?: The company employs 147,000 workers across the globe.
How can I contact NeutriSci International?: NeutriSci International's mailing address is 4th Floor, Willow House Cricket Square, George Town KY1-9010. The official website for the company is www.neutrisci.com. The company can be reached via phone at 403-264-6320.

This page (CVE:NU) was last updated on 3/20/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial